We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Miraculins Files with Health Canada for PreVu Medical Device License

News   Jan 17, 2012

 
Miraculins Files with Health Canada for PreVu Medical Device License
 
 
 

RELATED ARTICLES

Genetic Defect Linked to Pediatric Liver Disease

News

Researchers have discovered a genetic defect linked to Biliary atresia (BA), the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.

READ MORE

New Insights Into Alcohol and Tobacco Use

News

A recent study using data from 1.2 million people has discovered several genes associated with an increased use of alcohol and tobacco.

READ MORE

Antibody Therapy That Trains Phagocytes to Destroy Tumors Is Tested in Patients

News

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE